Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Megapharm is a premier Israeli pharmaceutical marketing and distribution company focused on bringing innovative therapies to the local market. Established in 1989, the company serves as a strategic partner for leading global biotechnology and pharmaceutical corporations, including Amgen, Gilead Sciences, and Alexion. Megapharm specializes in high-value therapeutic areas such as oncology, hematology, nephrology, and rare diseases. The company provides end-to-end commercialization services, encompassing regulatory registration, market access, medical affairs, and specialized logistics. By bridging the gap between international innovators and the Israeli healthcare system, Megapharm ensures that patients have access to cutting-edge medical treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Megapharm.